Merit Medical

Canaccord Genuity is pleased to announce that on July 6, 2016, Merit Medical Systems, Inc. (NASDAQ:MMSI), a leading manufacturer and marketer of proprietary disposable devices used primarily in cardiology, radiology and endoscopy, announced it has acquired DFINE, Inc., a privately held company developing therapeutic devices used to treat pathologies of the vertebrae.  According to the terms of the agreement, Merit Medical has acquired DFINE for approximately $97.5 million in cash, financed by a group of banks led by Wells Fargo and including Bank of America, HSBC and U.S. Bank.

Canaccord Genuity acted as financial advisor to Merit Medical and its Board of Directors in connection with the transaction. As part of its advisory services, Canaccord also provided a fairness opinion to the Board of Directors of Merit Medical.

Merit Medical, headquartered in South Jordan, Utah, is engaged in the development, manufacture and distribution of proprietary disposable medical devices used in interventional, diagnostic and therapeutic procedures, particularly in cardiology, radiology and endoscopy.  Merit Medical serves client hospitals worldwide and has approximately 3,900 employees.

DFINE, headquartered in San Jose, California, develops minimally invasive therapeutic devices used to treat pathologies of the vertebrae. DFINE’s product lines have 510(k) clearance and CE marking.